Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2001
10/09/2001US6300097 A polypeptide; therapy and diagnosis of bacterial infections; upper respiratory infections, toxic shock syndrome, septic arthritis and intestinal disorders
10/09/2001US6300094 Polynucleotides encoding a novel ABC transporter
10/09/2001US6300090 Delivering antigens to proliferating and non-proliferating dendritic cells using a nonreplicating influenza viral vector; the dentritic cells will process and express the antigen which will then activate cd8 cytotoxic t lymphocytes
10/09/2001US6300080 Screening molecular libraries to identify lead drug compounds that modulate adhesion between lymphocytes and cadherin expressing cells by performing adhesion assays with and without one molecular library member and compare results
10/09/2001US6300067 TFIIB transcription factor from Candida albicans and methods of screening for inhibitors of Candida albicans growth
10/09/2001US6300064 Protein/(poly)peptide libraries
10/09/2001US6299898 Methods and compositions for the treatment of wounds
10/09/2001US6299877 Used in therapy
10/09/2001US6299869 Human interferon-epsilon: a type I interferon
10/09/2001US6299650 Method for in vitro production of bone
10/09/2001CA2240289C Soaps produced from high laurate canola oil-based fatty acids
10/09/2001CA2235025C Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis
10/09/2001CA1341303C Lymphokine activated effector cells for antibody-dependent cellular cytotoxicity (adcc) treatment of cancer and other diseases
10/09/2001CA1341301C Preparation of functional human urokinase proteins
10/04/2001WO2001073094A2 Novel sperm-dna complexes for genetically modifying non-human animals
10/04/2001WO2001073093A2 Cell-specific adenovirus vectors comprising an internal ribosome entry site
10/04/2001WO2001073092A2 Interspecific dianthus plant
10/04/2001WO2001073087A1 Cestrum yellow leaf curling virus promoters
10/04/2001WO2001073086A2 Method for genetically modifying a plant
10/04/2001WO2001073078A1 A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus orf2, and an antigenic polypeptide
10/04/2001WO2001073075A2 Muskmelon cucumis melo hydroperoxide lyase and uses thereof
10/04/2001WO2001073052A2 Thermophilic polymerase iii holoenzyme
10/04/2001WO2001073034A2 Beta-like glycoprotein hormone polypeptide and heterodimer
10/04/2001WO2001073033A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains
10/04/2001WO2001073032A2 Compositions and methods for the therapy and diagnosis of prostate cancer
10/04/2001WO2001073029A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001073028A2 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor
10/04/2001WO2001073025A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains
10/04/2001WO2001073020A1 Materials and methods relating to a novel splice variant of a na+ dependent glutamate transporter
10/04/2001WO2001073018A2 Human tap-like protein (transporter associated in antigen processing/presentation)
10/04/2001WO2001073015A1 Identification of human gaba transporter
10/04/2001WO2001073014A1 Human survivin interacting protein 1 (sip-1)
10/04/2001WO2001073002A2 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
10/04/2001WO2001072996A1 A construct capable of release in closed circular form from a larger nucleotide sequence permitting site specific expression and/or developmentally regulated expression of selected genetic sequences
10/04/2001WO2001072994A2 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof
10/04/2001WO2001072984A1 Plant anthocyanidin rutinoside aromatic acyl transferases
10/04/2001WO2001072977A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/04/2001WO2001072970A2 Methods to prepare and use epidermal stem cells
10/04/2001WO2001072962A2 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
10/04/2001WO2001072961A2 Novel compounds
10/04/2001WO2001072954A2 Perfusion incubator
10/04/2001WO2001072953A1 Carrier for animal cell culture comprising organ tissue slice and animal cell culture method and transplantation method with the use of the carrier
10/04/2001WO2001072846A2 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof
10/04/2001WO2001072841A2 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001072840A2 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001072839A2 Human g-protein coupled receptors
10/04/2001WO2001072838A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001072836A2 G-protein coupled receptors
10/04/2001WO2001072829A2 Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
10/04/2001WO2001072822A2 Genes involved in intestinal inflammatory diseases and use thereof
10/04/2001WO2001072782A2 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
10/04/2001WO2001072781A2 Human genes and expression products
10/04/2001WO2001072780A2 Polynucleotides for diagnosing mammary gland cancer
10/04/2001WO2001072777A2 Human transcription factors
10/04/2001WO2001072776A2 Agent and method for reducing intraocular pressure
10/04/2001WO2001072773A2 Genes isolated from dendritic cells, gene products and methods employing the same
10/04/2001WO2001072772A2 Calcium binding regulatory subunit
10/04/2001WO2001072771A2 Insulin and igf-1 receptor agonists and antagonists
10/04/2001WO2001072768A2 Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same
10/04/2001WO2001072765A1 ALTERATION OF CELLULAR BEHAVIOR BY ANTISENSE MODULATION OF mRNA PROCESSING
10/04/2001WO2001072336A1 Compounds for targeting
10/04/2001WO2001072325A1 Methods of blocking tissue destruction by autoreactive t cells
10/04/2001WO2001072314A1 N-cam binding inhibits proliferation of and promotes differentiation of hippocampal progenitor cells
10/04/2001WO2001072295A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/04/2001WO2001072283A1 Cationic liposomes
10/04/2001WO2001072277A2 Immunotherapeutic methods and compositions
10/04/2001WO2001072132A1 Non-human transgenic animals expressing platelet-derived growth factor c (pdgf-c) and uses thereof
10/04/2001WO2001072120A2 A strategy for maintaining pregnancy
10/04/2001WO2001036638A8 Polypeptides and nucleic acids encoding same
10/04/2001WO2001036602A3 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same
10/04/2001WO2001035989A3 Use of anti-idiotypical antibodies as vaccines against cancer
10/04/2001WO2001032685A3 Gene expression directed by a super-psa promoter
10/04/2001WO2001032129A3 Augmentation and repair of age-related soft tissue defects
10/04/2001WO2001030970A3 Improved protocol for activation of oocytes
10/04/2001WO2001022990A3 Methods related to immunostimulatory nucleic acid-induced interferon
10/04/2001WO2001021784A3 Pcna-associated cell cycle proteins, compositions and methods of use
10/04/2001WO2001021644A3 Wheat dp proteins and uses thereof
10/04/2001WO2001019961A3 Method for cultivating living cells, especially mature fat cells, which are prepared from tissue and float in liquids
10/04/2001WO2001019955A3 Lysosomal targeting pathway enzymes
10/04/2001WO2001016319A3 Compositions and methods for the treatment of immune related diseases
10/04/2001WO2001012800A3 Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and dimorphecolic acid, a fatty acid containing a 9-hydroxy group and delta-10,12 conjugated double bonds
10/04/2001WO2001011047A3 Dna sequences isolated from human colonic epithelial cells
10/04/2001WO2000071564A8 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
10/04/2001WO2000047625A9 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
10/04/2001WO2000043515A3 Methods of monitoring hiv drug resistance
10/04/2001WO2000042074A9 Anti-ccr4 antibodies and methods of use therefor
10/04/2001WO2000039279A9 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/04/2001WO2000017327A9 Terpene synthases
10/04/2001WO2000007018A3 Three-hybrid screening method for ligand-protein interactions
10/04/2001WO1999055860A8 Host-encoded protein expressed on marek's disease (mdv)-infected cells and antibody thereto
10/04/2001WO1999046387A9 Biosynthetic genes for spinosyn insecticide production
10/04/2001US20010027569 Method of fertilizing an avian egg in the shell
10/04/2001US20010027567 DNA molecule encoding recombinatorial substrate and reporter gene; activation by recombinase to effect gain or loss of gene function; transgenic mammal with said DNA; identification of transgene by phenotype of reporter gene
10/04/2001US20010027566 Transgenic animal model of basal cell carcinoma
10/04/2001US20010027184 Serine/threonine protein kinase (H-SGK2)
10/04/2001US20010027182 Spinocerebellar ataxia type 1 (SCA1); using chaperone proteins to aid in recognition/hydrolysis of mutant ataxin-1 by the proteasome; treating Alzheimer's, Parkinson's, prion disorders, dentatorubral-pallidoluysian atrophy and SCA1
10/04/2001US20010026941 Methods and compositions for the introduction of molecules into cells
10/04/2001US20010026940 Biopesticides
10/04/2001US20010026938 Containing DNA expressing the adenovirus protease; for gene transfer purposes, vaccines
10/04/2001US20010026937 Culturing population of peripheral blood or bone marrow mononuclear cells in interleukin-4, granulocyte macrophage colony stimulating factor, and culture medium comprising insulin, transferrin, linoleic acid, oleic acid, palmitic acid
1 ... 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 ... 1827